> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Pediatric Studies for Dermatitis Drugs
- URL: https://www.fdaweb.com/draft-guide-on-pediatric-studies-for-dermatitis-drugs/
- Published: 2018-04-09T12:00:00.000Z
- Updated: 2026-09-14T23:58:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141173

*Federal Register* notice: FDA has made available a draft guidance on “Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs.” The document discusses how early in drug development pediatric patients should be incorporated when evaluating systemic drugs for atopic dermatitis. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-04-09/pdf/2018-07150.pdf?ref=fdaweb.com).